Haleon Plc Correlations

HLN Stock

USD 9.48 0.28 3.04%

The current 90-days correlation between Haleon plc and Viatris is 0.39 (i.e., Weak diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Haleon Plc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Haleon plc moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Haleon Plc Correlation With Market

Average diversification

The correlation between Haleon plc and DJI is 0.17 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Haleon plc and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with Haleon Stock

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Haleon plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.

To learn how to invest in Haleon Stock, please use our How to Invest in Haleon Plc guide.

Moving together with Haleon Stock

0.73

VPRO

Viropro

Pair Corr

Moving against Haleon Stock

0.76	RAC	Race Oncology	Pair Corr
0.69	VERA	Vera Therapeutics	Pair Corr
0.58	DNTH	Dianthus Therapeutics	Pair Corr
0.57	DRUG	Bright Minds Biosciences	Pair Corr
0.55	CMB	Cambium Bio	Pair Corr
0.52	VCYT	Veracyte	Pair Corr
0.49	688578	Shanghai Allist Phar	Pair Corr
0.41	DMAC	DiaMedica Therapeutics	Pair Corr
0.39	AVH	Avita Medical	Pair Corr
0.38	VALN	Valneva SE ADR	Pair Corr
0.38	VANI	Vivani Medical Buyout Trend	Pair Corr
0.7	DRTS	Alpha Tau Medical	Pair Corr
0.67	DWTX	Dogwood Therapeutics,	Pair Corr
0.66	CDIOW	Cardio Diagnostics	Pair Corr
0.64	DYAI	Dyadic International	Pair Corr
0.53	DXB	Dimerix	Pair Corr
0.48	DSGN	Design Therapeutics	Pair Corr
0.47	VIVS	VivoSim Labs, Symbol Change	Pair Corr
0.38	DTIL	Precision BioSciences	Pair Corr
0.7	VTVT	vTv Therapeutics	Pair Corr
0.68	BSFA	BSF Enterprise Plc	Pair Corr
0.63	EDIT	Editas Medicine	Pair Corr
0.51	VRDN	Viridian Therapeutics Buyout Trend	Pair Corr
0.5	VNDA	Vanda Pharmaceuticals	Pair Corr
0.47	EDSA	Edesa Biotech	Pair Corr

Related Correlations Analysis

	VTRS	TAK	ELAN	ZTS	EBS	OGN	WDS	KD	GSK
VTRS		0.68	0.66	0.38	0.73	0.03	0.12	-0.58	0.52	VTRS
TAK	0.68		0.35	0.45	0.34	0.31	0.25	-0.18	0.16	TAK
ELAN	0.66	0.35		-0.38	0.84	0.41	-0.54	-0.76	0.91	ELAN
ZTS	0.38	0.45	-0.38		-0.14	-0.35	0.78	0.3	-0.43	ZTS
EBS	0.73	0.34	0.84	-0.14		0.1	-0.37	-0.72	0.74	EBS
OGN	0.03	0.31	0.41	-0.35	0.1		-0.42	0.12	0.46	OGN
WDS	0.12	0.25	-0.54	0.78	-0.37	-0.42		0.26	-0.65	WDS
KD	-0.58	-0.18	-0.76	0.3	-0.72	0.12	0.26		-0.65	KD
GSK	0.52	0.16	0.91	-0.43	0.74	0.46	-0.65	-0.65		GSK
	VTRS	TAK	ELAN	ZTS	EBS	OGN	WDS	KD	GSK

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

GSK	+ 0.91	ELAN
EBS	+ 0.84	ELAN
WDS	+ 0.78	ZTS
GSK	+ 0.74	EBS
EBS	+ 0.73	VTRS
TAK	+ 0.68	VTRS

High negative correlations

KD	- 0.76	ELAN
KD	- 0.72	EBS
GSK	- 0.65	KD
GSK	- 0.65	WDS
KD	- 0.58	VTRS
WDS	- 0.54	ELAN

Risk-Adjusted Indicators

There is a big difference between Haleon Stock performing well and Haleon Plc Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Haleon Plc's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
VTRS	1.34	0.13	0.06	0.21	1.68	(1.34)	2.91	(2.59)	10.90
TAK	0.91	(0.08)	0.00	(0.06)	0.00	0.00	1.40	(2.15)	6.40
ELAN	1.81	0.53	0.32	0.60	1.27	(2.25)	3.65	(2.57)	20.94
ZTS	0.94	(0.10)	0.00	(0.07)	0.00	0.00	2.20	(1.78)	6.75
EBS	3.37	0.40	0.13	0.27	2.96	(4.58)	8.53	(5.33)	46.31
OGN	1.92	(0.09)	0.00	(0.02)	0.00	0.00	3.92	(3.40)	17.08
WDS	1.17	(0.13)	0.00	(0.13)	0.00	0.00	2.09	(3.45)	8.40
KD	1.74	(0.57)	0.00	(0.28)	0.00	0.00	2.56	(3.82)	23.26
GSK	1.20	0.27	0.16	0.45	1.24	(1.30)	3.14	(1.64)	9.44

Haleon Plc Corporate Management

Tamara Rogers	Chief Officer	Profile
Adrian Morris	General Counsel	Profile
Brian McNamara	CEO Director	Profile
Bjarne Tellmann	General Counsel	Profile
Claire Dickson	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC